Homestead Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-321,540
Closed -$35.7M 134
2022
Q1
$35.7M Sell
321,540
-124,700
-28% -$13.2M 0.87% 44
2021
Q4
$46.2M Sell
446,240
-197,800
-31% -$22.9M 1.06% 40
2021
Q3
$80.7M Buy
644,040
+3,400
+0.5% +$440K 1.96% 17
2021
Q2
$79.5M Sell
640,640
-7,300
-1% -$917K 1.84% 16
2021
Q1
$76.5M Sell
647,940
-33,600
-5% -$3.94M 1.83% 19
2020
Q4
$79.8M Sell
681,540
-18,200
-3% -$2M 1.97% 17
2020
Q3
$72.7M Sell
699,740
-62,400
-8% -$6.27M 1.99% 15
2020
Q2
$69.9M Buy
762,140
+800
+0.1% +$76.7K 1.8% 23
2020
Q1
$68.7M Sell
761,340
-21,913
-3% -$2.33M 2.02% 17
2019
Q4
$88.9M Sell
783,253
-6,755
-0.9% -$741K 1.85% 20
2019
Q3
$85.8M Sell
790,008
-23,695
-3% -$2.47M 1.73% 19
2019
Q2
$79.2M Sell
813,703
-180,000
-18% -$16.4M 1.5% 22
2019
Q1
$90.5M Sell
993,703
-374,000
-27% -$33.5M 1.69% 24
2018
Q4
$124M Buy
1,367,703
+2,000
+0.1% +$187K 2.42% 17
2018
Q3
$134M Hold
1,365,703
2.06% 18
2018
Q2
$117M Buy
1,365,703
+3,000
+0.2% +$251K 1.84% 20
2018
Q1
$109M Hold
1,362,703
1.64% 22
2017
Q4
$110M Hold
1,362,703
1.57% 21
2017
Q3
$106M Hold
1,362,703
1.61% 23
2017
Q2
$121M Hold
1,362,703
1.89% 19
2017
Q1
$110M Hold
1,362,703
1.75% 22
2016
Q4
$97.1M Hold
1,362,703
1.53% 26
2016
Q3
$118M Hold
1,362,703
1.95% 18
2016
Q2
$118M Hold
1,362,703
2.03% 16
2016
Q1
$102M Buy
+1,362,703
New +$103M 1.83% 20

Other funds holding MDT

Homestead Advisers's MDT Position: Q2 2022 in Review

Homestead Advisers sold out of Medtronic (MDT) in Q2 2022, closing a stake of 321,540 shares — an estimated $35.7M sold.

Homestead Advisers first reported a position in MDT in Q1 2016 and held it in 25 quarters. The position peaked at $134M in Q3 2018. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Homestead Advisers reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Homestead Advisers sold 321,540 Medtronic shares in Q2 2022, an estimated $35.7M.
  • Homestead Advisers first reported a position in Medtronic in Q1 2016 and held it in 25 quarters.
  • Homestead Advisers's Medtronic position peaked at $134M in Q3 2018.
  • 2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Homestead Advisers's 13F filing for Q2 2022, filed 1 Aug 2022.